Back to “Normal?”: The Department of Defense’s Role in COVID-19 Screening and Diagnostics

[Available On-Demand]
Search General Info
How do we stop the spread of the novel coronavirus and safely treat those with COVID-19 if we don’t know who has the disease? Leading experts from the Department of Defense, the U.S. Department of Health and Human Services, and industry will discuss the important role screening and diagnostics capabilities play in slowing the spread of the virus. The panel will delve into the progressive methods, resources, and partnerships being leveraged to meet the relentless demand for COVID-19 testing, as well as the successes, challenges, and lessons learned from operating in such unique circumstances.
Moderator
photo
Vice President, Infectious Diseases and Diagnostics Policy
Biotechnology Innovation Organization
Speakers
photo
Vice President, Infectious Diseases and Diagnostics Policy
Biotechnology Innovation Organization
photo
Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical
CCDC Chemical Biological Center
photo
Vice President, Government Programs
Cepheid
photo
Senior Director Medical Regulatory/Senior Regulatory Advisor
JPEO CBRND and Defense Threat Reduction Agency / Joint Science and Technology Office (DTRA / JSTO)
photo
Deputy Joint Program Executive Officer
Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense
photo
Vice President of Sales and Marketing
BioFire